Literature DB >> 10063909

Healing of Helicobacter pylori-induced gastric ulcers in Mongolian gerbils: combined treatment with omeprazole and clarithromycin.

Y Keto1, S Takahashi, S Okabe.   

Abstract

Helicobacter pylori can colonize the stomachs of Mongolian gerbils and subsequently induce penetrating ulcers five months later. Using this gerbil model, the effects of both combined treatment with omeprazole and clarithromycin, as well as treatment with each drug separately, on the healing of H. pylori-induced gastric ulcers, and the effects of the cessation of the drug treatment on healed ulcers were examined. Beginning five months after H. pylori (NCTC11637) inoculation, omeprazole (four weeks), clarithromycin (two weeks), their combination, or the vehicle was orally administered once daily. These drugs, in combination or separately, markedly enhanced ulcer healing and lowered the increased myeloperoxidase (MPO) activity. While omeprazole had no effect on viable H. pylori, clarithromycin and the drug combination significantly reduced viable H. pylori. The degree of bacterial eradication was much higher in the case of the drug combination compared to clarithromycin alone. Four months after cessation of the treatment, visible ulcers, hypertrophic gastritis and increased MPO activity were found in the control animals (all H. pylori-positive). Nonetheless, only one of the eight gerbils subjected to the drug combination developed a small ulcer, although no hypertrophic gastritis was exhibited. It is concluded that: (1) the gerbil model of H. pylori infection is useful for the study of ulcer healing; (2) combined treatment with omeprazole and clarithromycin enhances the ulcer healing in infected gerbils; and (3) healed ulcers do not relapse, despite cessation of the drug treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10063909     DOI: 10.1023/a:1026685929992

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

1.  Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study.

Authors:  R W Van der Hulst; E A Rauws; B Köycü; J J Keller; M J Bruno; J G Tijssen; G N Tytgat
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

2.  Pathological changes in the formation of Helicobacter pylori-induced gastric lesions in Mongolian gerbils.

Authors:  S Takahashi; Y Keto; H Fujita; H Muramatsu; T Nishino; S Okabe
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

3.  Induction of gastric ulcer and intestinal metaplasia in mongolian gerbils infected with Helicobacter pylori.

Authors:  F Hirayama; S Takagi; H Kusuhara; E Iwao; Y Yokoyama; Y Ikeda
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

4.  A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain.

Authors:  A Lee; J O'Rourke; M C De Ungria; B Robertson; G Daskalopoulos; M F Dixon
Journal:  Gastroenterology       Date:  1997-04       Impact factor: 22.682

5.  Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.

Authors:  T Lind; S Veldhuyzen van Zanten; P Unge; R Spiller; E Bayerdörffer; C O'Morain; K D Bardhan; M Bradette; N Chiba; M Wrangstadh; C Cederberg; J P Idström
Journal:  Helicobacter       Date:  1996-09       Impact factor: 5.753

6.  Establishment of gastric Helicobacter pylori infection in Mongolian gerbils.

Authors:  F Hirayama; S Takagi; Y Yokoyama; E Iwao; Y Ikeda
Journal:  J Gastroenterol       Date:  1996-11       Impact factor: 7.527

7.  Helicobacter pylori infection induces gastric cancer in mongolian gerbils.

Authors:  T Watanabe; M Tada; H Nagai; S Sasaki; M Nakao
Journal:  Gastroenterology       Date:  1998-09       Impact factor: 22.682

8.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

Authors:  J E Krawisz; P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

9.  Short report: the effect of omeprazole on Helicobacter pylori and associated gastritis.

Authors:  M A Daw; P Deegan; E Leen; C O'Moráin
Journal:  Aliment Pharmacol Ther       Date:  1991-08       Impact factor: 8.171

10.  Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada.

Authors:  B O'Brien; R Goeree; A H Mohamed; R Hunt
Journal:  Arch Intern Med       Date:  1995-10-09
View more
  10 in total

1.  Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils.

Authors:  M Takashima; T Furuta; H Hanai; H Sugimura; E Kaneko
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses.

Authors:  D A Israel; N Salama; C N Arnold; S F Moss; T Ando; H P Wirth; K T Tham; M Camorlinga; M J Blaser; S Falkow; R M Peek
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

3.  Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori.

Authors:  Guofei Dai; Ni Cheng; Lei Dong; Mutsumi Muramatsu; Shudong Xiao; Ming-Wei Wang; De-Xu Zhu
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

4.  Influence of Helicobacter pylori infection on healing and relapse of acetic acid ulcers in Mongolian gerbils.

Authors:  Yoshihiro Keto; Misako Ebata; Kazuyoshi Tomita; Susumu Okabe
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

5.  Antisecretory and ulcer healing effects of S-0509, a novel CCK-B/gastrin receptor antagonist, in rats.

Authors:  K Amagase; K Ikeda; S Okabe
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

6.  In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection.

Authors:  T Kanamaru; Y Nakano; Y Toyoda; K I Miyagawa; M Tada; T Kaisho; M Nakao
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

7.  Eradication of Helicobacter pylori significantly reduced gastric damage in nonsteroidal anti-inflammatory drug-treated Mongolian gerbils.

Authors:  Chun-Chao Chang; Sheng-Hsuan Chen; Gi-Shih Lien; Horng-Yuan Lou; Ching-Ruey Hsieh; Chia-Lang Fang; Shiann Pan
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

8.  Anti-Helicobacter pylori therapy significantly reduces Helicobacter pylori -induced gastric mucosal damage in Mongolian gerbils.

Authors:  Chun-Chao Chang; Sheng-Hsuan Chen; Gi-Shih Lien; Yuarn-Jang Lee; Horng-Yuan Lou; Ching-Ruey Hsieh; Chia-Lang Fang; Shiann Pan
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

9.  Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils.

Authors:  Toshio Watanabe; Kazuhide Higuchi; Masaki Hamaguchi; Tetsuya Tanigawa; Rikimon Wada; Kazunari Tominaga; Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

10.  Rapid loss of motility of Helicobacter pylori in the gastric lumen in vivo.

Authors:  Sören Schreiber; Roland Bücker; Claudia Groll; Marina Azevedo-Vethacke; Désirée Garten; Peter Scheid; Susanne Friedrich; Sören Gatermann; Christine Josenhans; Sebastian Suerbaum
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.